Fiscal 2025 Q4 Earnings June 25, 2025 General Mills Fiscal 2025 Fourth Quarter A Reminder on Forward-looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's current expectations and assumptions. These forward-looking statements including the statements under the caption "Fiscal 2026 Outlook," and statements made by Mr. Harmening, are subject to certain risks and uncertainties that could ...

Company Performance & Financials - Essex has achieved a +14.4% CAGR since its IPO, demonstrating best-in-class total returns[6] - Essex has increased its cash dividend for 30 consecutive years, with 487% cumulative dividend growth since its IPO in 1994[11] - The company's controllable operating expense margin has outperformed its peer group by 290 bps on average since 2020[27] - The company expects structured finance redemptions of approximately $125 - $175 million[93] - The company's total market capitalization is $24.4 billion[6, 95] Portfolio & Market Overview - The company's portfolio consists of 255 apartment communities with over 62,000 apartment homes[32] - Southern California accounts for 43% of the company's portfolio NOI at pro rata share, Northern California 40%, and Seattle 17%[35] - It is 2.6x more expensive to own versus rent in Essex markets[60] - Total housing supply growth in the Essex markets is forecasted to remain constant at only 0.5% of housing stock in 2024[81] ESG Initiatives - The company has collected over $10 million in rebates since 2009 through its environmental initiatives[100] - The company has invested approximately $10 million in energy efficiency, $20 million in renewable energy, and $2 million in water conservancy[103]

Business Overview - 23andMe operates with two business verticals: Consumer and Research[11] - The Consumer business focuses on personalized health services, ancestry, and recurring subscription revenue[13] - The Research business leverages the world's largest re-contactable genetic and phenotypic data engine for data licensing, target discovery, and research services for pharma[15] - The company has genotyped over 15 million customers, with over 84% of customers opting-in to research, generating 4.8 billion phenotypic data points[17] Consumer Health - Genetics plays a role in 8 out of the 10 leading causes of death in the US[24] - 23andMe helps consumers identify their genetic risks, with over 28,000 customers identified with BRCA1/BRCA2 variants and over 4 million with a higher likelihood of type 2 diabetes[32] - 76% of customers report taking a positive health action after learning about their genetics[33] - 23andMe offers direct access to care with Lemonaid Health Telehealth Services, including access to GLP-1 drugs for weight loss in a number of states[43, 47] Research and AI - 23andMe has a large biobank with over 9 million research participants with ILD data sharing consent and over 5 million biobanked samples[65] - The company is pursuing multiple approaches to integrate Claims and EHR data into its existing data ecosystem, with over 5 million 23andMe customers having both Claims and EHR data[67, 71] - 23andMe is investing in AI to drive the next wave of insights and value-creation, leveraging its large-scale, relevant, and unique data[93] Financials - In FY2024, PGS revenue was $168 million with subscription revenue of $20 million[57] - For the three months ended December 31, 2024, Consumer Services revenue was $40 million (66% of total revenue) and Research Services revenue was $21 million (34% of total revenue)[104] - Total revenue for the three months ended December 31, 2024, was $60 million, compared to $45 million for the same period in FY2024[104] - Total revenue for FY2024 was $220 million, with Consumer Services accounting for $202 million (92%) and Research Services accounting for $17 million (8%)[104] - The company has $216 million in cash to support its plans for targeted investment in high ROI growth initiatives[103]

Mark Stolper Chief Financial Officer ms@radnet.com December 2024 NASDAQ: RDNT Safe Harbor This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning RadNet's ability to continue to grow the business by generating patient referrals and contracts with radiology practices, integrate acquired businesses, recruit and retain technologists, and receive third-party reimbursement for diagnostic imaging ser ...

slido.com event code: #EXPI Q1 2024 Financial Results Virtual Fireside Chat May 1, 2024 Q1 2024 Earnings Glenn Sanford Founder, Chairman & Chief Executive Officer, eXp World Holdings Leo Pareja We assume no obligation to update or revise any forward-looking statements or information. 1Within the meaning of the Private Securities Litigation Reform Act of 1995 Excluding the information from sources indicated, the content of this presentation is copyright 2024 eXp World Holdings, Inc. All Rights Reserved. Chie ...

Financial Performance - Revenue increased by 5% from $1,231.1 million in Q2 2023 to $1,295.2 million in Q2 2024[43] - Adjusted EBITDA increased by 22% from $26.8 million in Q2 2023 to $32.8 million in Q2 2024[21, 43] - North America Adjusted EBITDA grew by 13% year-over-year[21, 37] - International realty revenue increased by 69% year-over-year[21] - Share repurchases amounted to $48.2 million during the quarter[46] Operating Metrics - Real estate sales transactions increased by 1% from 119,277 in Q2 2023 to 120,613 in Q2 2024[21, 43] - Real estate sales volume increased by 7% from $48.6 billion in Q2 2023 to $51.9 billion in Q2 2024[21, 43, 55] - North American Realty SG&A/Unit improved 9% year-over-year[21, 35] - Cost per transaction decreased by 8% from $533 in Q2 2023 to $488 in Q2 2024[43, 46] Agent-Related Updates - eXp paid out nearly $7 million in Real Time REVshare in the first 60 days of REVenue Share 2.0[30] - eXp Exclusives participation expanded by 24% quarter over quarter[33] - eXp Luxury agent count grew by 130% compared to Q2 2023[33]

slido.com event code: #EXPI Glenn Sanford Founder, Chairman & Chief Executive Officer, eXp World Holdings Leo Pareja Chief Executive Officer, eXp Realty Principal Financial Officer, Chief Accounting Officer, eXp World Holdings Wendy Forsythe Q3 2024 Financial Results Virtual Fireside Chat November 7, 2024 Q3 2024 Earnings Speakers We assume no obligation to update or revise any forward-looking statements or information. 1Within the meaning of the Private Securities Litigation Reform Act of 1995 Chief Market ...

Company Overview - Genasys has a market capitalization of $150 million, with $14 million in cash and $15 million in debt as of December 31, 2024[7] - The company estimates a total addressable market (TAM) of $5.5 billion[7] - Genasys Protect platform is used in over 100 countries worldwide[7] Recent Contracts and Projects - Genasys received over $10 million in cash deposits for the first two approved groups of Puerto Rico dams[13] - FEMA approved over $41.3 million for the construction phase of the Early Warning System (EWS) for 17 dams in 12 municipalities in Puerto Rico[16] - The Puerto Rico Early Warning System (EWS) project is fully funded by FEMA for $94.3 million[17] CROWS EOF Program - The FY24 DOD Appropriations Bill added $20 million to the CROWS program ($5 million for RDT&E and $15 million for Procurement)[25] - Tech Feasibility Study phase II cost $950K[25] California Market - Genasys Protect covers 25 million of California's 39.5 million population[32] - Genasys Protect is used in 36 of California's 58 counties[32]

Company Overview - Monro, Inc is a leading national automotive service and tire provider with 1,296 locations in 32 states[10, 13] - The company's fiscal 2023 sales reached $1,325.4 million[7] - Monro has expanded through 33 acquisitions in the past 9 years, adding 429 locations and $626 million in revenue, entering 10 new states[10] Industry Trends - The automotive aftermarket's "Do-It-For-Me" (DIFM) segment is valued at $311 billion, within the larger $389 billion U S automotive aftermarket industry[24] - The number of vehicles in operation (VIO) is over 280 million, with an increasing average vehicle age of approximately 12 years[23] Financial Performance - In the third quarter of fiscal year 2024, sales decreased by 5.2% to $317.7 million, primarily due to lower tire unit sales[32, 36] - Comparable store sales decreased by 6.1% in Q3FY24, compared to an increase of 5.6% in Q3FY23[32, 36] - The gross margin improved to 35.5% in Q3FY24, a 170 basis points increase from 33.8% in Q3FY23[36] - Adjusted diluted EPS for Q3FY24 was $0.39, a 9.3% decrease compared to $0.43 in Q3FY23[36] Capital Allocation - Year-to-date fiscal 2024, Monro generated approximately $130 million in operating cash flow[32, 40] - The company repurchased approximately 1.5 million shares of common stock at an average price of $28.50, totaling approximately $44 million[40]

Seres Therapeutics Investor Presentation May 2025 Disclaimers 2 Seres Therapeutics, Inc. © 2025 2 Transforming patient outcomes using proprietary consortia of live biotherapeutics Strong Foundation Forward Looking Statements This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this communication that do not relate to matters of historical fact should be considered forward-looking statements, including s ...